Jiuzhoutong Pharmaceutical Investment (Hubei) Co., Ltd. announced that it will receive CNY 10,910,068,900 in a round of funding on October 27, 2023 The transaction will include participation from returning investor, Jointown Pharmaceutical Group Co., Ltd. The transaction has been approved at the 27th meeting of the 5th directorate of Jointown Pharmaceutical Group Co., Ltd. and this does not need the approval of shareholders. The registered capital of the company is CNY 600,000,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.19 CNY | -1.92% | -0.24% | +16.83% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.83% | 4.32B | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+8.25% | 8.38B | |
+5.13% | 8.59B | |
-19.42% | 8.09B | |
+5.56% | 4.81B | |
-1.83% | 4.05B | |
-1.65% | 3.93B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd